739 related articles for article (PubMed ID: 19715413)
1. Pathological and physiological left ventricular hypertrophy: echocardiography for differentiation.
Chelliah RK; Senior R
Future Cardiol; 2009 Sep; 5(5):495-502. PubMed ID: 19715413
[TBL] [Abstract][Full Text] [Related]
2. Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy.
Caselli S; Maron MS; Urbano-Moral JA; Pandian NG; Maron BJ; Pelliccia A
Am J Cardiol; 2014 Nov; 114(9):1383-9. PubMed ID: 25217454
[TBL] [Abstract][Full Text] [Related]
3. [Physiological versus pathological left ventricular remodeling in athletes].
Quattrini FM; Pelliccia A
G Ital Cardiol (Rome); 2012 Apr; 13(4):273-80. PubMed ID: 22495644
[TBL] [Abstract][Full Text] [Related]
4. Right ventricular myocardial involvement in either physiological or pathological left ventricular hypertrophy: an ultrasound speckle-tracking two-dimensional strain analysis.
D'Andrea A; Caso P; Bossone E; Scarafile R; Riegler L; Di Salvo G; Gravino R; Cocchia R; Castaldo F; Salerno G; Golia E; Limongelli G; De Corato G; Cuomo S; Pacileo G; Russo MG; Calabrò R
Eur J Echocardiogr; 2010 Jul; 11(6):492-500. PubMed ID: 20551250
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular hypertrophy in athletes.
Rawlins J; Bhan A; Sharma S
Eur J Echocardiogr; 2009 May; 10(3):350-6. PubMed ID: 19246500
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of various "classic" echocardiographic and laboratory indices in distinguishing the "gray zone" between athlete's heart and hypertrophic cardiomyopathy: a pilot study.
Pagourelias ED; Efthimiadis GK; Kouidi E; Zorou P; Giannoglou G; Deligiannis A; Athyros VG; Karagiannis A; Geleris P
Echocardiography; 2013 Feb; 30(2):131-9. PubMed ID: 23167844
[TBL] [Abstract][Full Text] [Related]
7. [Athlete's heart and hypertrophic cardiomyopathy: contribution on clinical and morphologic differentiation].
Bahlmann E; Kuck KH; Nienaber CA
Dtsch Med Wochenschr; 2015 Jul; 140(15):1158-64. PubMed ID: 26230069
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of Doppler myocardial imaging in the study of the athlete's heart and in the differential diagnosis between physiological and pathological ventricular hypertrophy.
D'Andrea A; D'Andrea L; Caso P; Scherillo M; Zeppilli P; Calabrò R
Echocardiography; 2006 Feb; 23(2):149-57. PubMed ID: 16445736
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing left ventricular hypertrophy from hypertrophic cardiomyopathy in adolescents: a longitudinal observation study.
Forså MI; Smedsrud MK; Haugaa KH; Bjerring AW; Früh A; Sarvari SI; Landgraff HW; Hallén J; Edvardsen T
Eur J Prev Cardiol; 2024 Mar; 31(5):591-598. PubMed ID: 37992187
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of hypertrophic cardiomyopathy from other forms of left ventricular hypertrophy by means of three-dimensional echocardiography.
Caselli S; Pelliccia A; Maron M; Santini D; Puccio D; Marcantonio A; Pandian NG; De Castro S
Am J Cardiol; 2008 Sep; 102(5):616-20. PubMed ID: 18721523
[TBL] [Abstract][Full Text] [Related]
11. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete's heart and hypertrophic cardiomyopathy.
Sharma S; Maron BJ; Whyte G; Firoozi S; Elliott PM; McKenna WJ
J Am Coll Cardiol; 2002 Oct; 40(8):1431-6. PubMed ID: 12392833
[TBL] [Abstract][Full Text] [Related]
12. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes.
Maron BJ; Pelliccia A; Spataro A; Granata M
Br Heart J; 1993 Feb; 69(2):125-8. PubMed ID: 8435237
[TBL] [Abstract][Full Text] [Related]
13. The demanding grey zone: Sport indices by cardiac magnetic resonance imaging differentiate hypertrophic cardiomyopathy from athlete's heart.
Czimbalmos C; Csecs I; Toth A; Kiss O; Suhai FI; Sydo N; Dohy Z; Apor A; Merkely B; Vago H
PLoS One; 2019; 14(2):e0211624. PubMed ID: 30763323
[TBL] [Abstract][Full Text] [Related]
14. Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete's heart from pathologic hypertrophy.
Pelliccia A; Maron MS; Maron BJ
Prog Cardiovasc Dis; 2012; 54(5):387-96. PubMed ID: 22386289
[TBL] [Abstract][Full Text] [Related]
15. Differentiating the athlete's heart from hypertrophic cardiomyopathy.
Wasfy MM; Weiner RB
Curr Opin Cardiol; 2015 Sep; 30(5):500-5. PubMed ID: 26196658
[TBL] [Abstract][Full Text] [Related]
16. Athlete's heart or hypertrophic cardiomyopathy?
Lauschke J; Maisch B
Clin Res Cardiol; 2009 Feb; 98(2):80-8. PubMed ID: 18853091
[TBL] [Abstract][Full Text] [Related]
17. [Sigmoid septum: A variant of the ventricular hypertrophy or of the hypertrophic cardiomyopathy?].
Gentille-Lorente D; Salvadó-Usach T
Arch Cardiol Mex; 2016; 86(2):110-22. PubMed ID: 27019990
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients.
Klues HG; Schiffers A; Maron BJ
J Am Coll Cardiol; 1995 Dec; 26(7):1699-708. PubMed ID: 7594106
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of two-dimensional and speckle tracking echocardiography in "Gray Zone" left ventricular hypertrophy to differentiate professional football player's heart from hypertrophic cardiomyopathy.
Kansal MM; Lester SJ; Surapaneni P; Sengupta PP; Appleton CP; Ommen SR; Ressler SW; Hurst RT
Am J Cardiol; 2011 Nov; 108(9):1322-6. PubMed ID: 21855830
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
